Diabetes mellitus is a chronic metabolic disorder characterised by hyperglycaemia due to insulin deficiency, resistance, or both.
It primarily exists in two forms: Type 1 and Type 2, with distinct aetiologies and management approaches
Type 1 (10%) – DM1 – where the pancreas does not produce any insulin. This type is usually diagnosed in childhood or as a young adult
Type 2 (90%) – DM2 – where the pancreas does not produce enough insulin or the body’s cells don’t react to insulin (resistance). This type usually affects older people.
Early diagnosis and appropriate management are crucial in preventing complications such as cardiovascular disease, neuropathy, retinopathy, and nephropathy.
Management focuses on lifestyle modifications, glucose monitoring, and pharmacological treatments.
Education and regular monitoring are essential in the prevention and management of diabetes complications.
1. Definition
Diabetes mellitus (DM) is a chronic condition characterised by elevated blood glucose levels (hyperglycaemia) resulting from either inadequate insulin production, impaired insulin action, or both
It is classified mainly into Type 1 Diabetes (DM1), Type 2 Diabetes (DM2), and gestational diabetes, with other specific forms linked to genetic, drug-induced, or pancreatic disease.
2. Epidemiology
Prevalence: Diabetes is a growing health concern worldwide, with over 4 million people diagnosed in the UK. Approximately 90% of cases are DM2, while 8% are DM1, and the remaining 2% are other specific types.
Incidence: DM1 commonly presents in childhood or early adulthood, whereas DM2 typically occurs in middle-aged and older adults but is increasingly seen in younger populations.
Gender: DM1 has no significant gender predilection, while DM2 slightly favours males.
Trends: The incidence of diabetes, particularly DM2, is rising due to increasing rates of obesity, sedentary lifestyles, and an aging population.
3. Risk factors
Type 1 Diabetes
Family history of DM1
Genetic predisposition (e.g., HLA-DR3, HLA-DR4)
Environmental factors (e.g. viral infections such as Coxsackie B, enteroviruses)
Type 2 Diabetes
Family history of diabetes
Obesity, particularly central adiposity
Sedentary lifestyle
Poor diet (high in refined carbohydrates and sugars)
Age >45 years
Ethnicity (higher risk in South Asian, African-Caribbean, and Black African populations)
History of gestational diabetes
Polycystic ovary syndrome (PCOS)
4. Causes
Type 1 Diabetes
Autoimmune destruction of pancreatic beta cells, leading to absolute insulin deficiency.
Genetic susceptibility combined with environmental triggers, such as viral infections, may precipitate the autoimmune response.
Type 2 Diabetes
Insulin resistance in peripheral tissues (muscle, liver, adipose) and a relative insulin deficiency.
Over time, the pancreas may fail to produce sufficient insulin to maintain normal blood glucose levels.
5. Symptoms
Classic symptoms: Polyuria, polydipsia, polyphagia, and unintentional weight loss (more common in DM1).
Other symptoms: Fatigue, blurred vision, recurrent infections (e.g., thrush, skin infections), slow-healing wounds, tingling or numbness in extremities.
Type-specific presentation: DM1 may present acutely with diabetic ketoacidosis (DKA), while DM2 often has a more insidious onset and may be asymptomatic for years.
6. Diagnosis
Diagnostic criteria
Fasting Plasma Glucose (FPG): ≥7.0 mmol/L
Random Plasma Glucose: ≥11.1 mmol/L in symptomatic individuals
HbA1c: ≥48 mmol/mol (6.5%)
Oral Glucose Tolerance Test (OGTT): 2-hour plasma glucose ≥11.1 mmol/L
Note.Diagnosis requires confirmation with repeat testing unless symptomatic hyperglycemia is present.
Investigation
Blood tests: FPG, random glucose, HbA1c
Urinalysis: For glucose, ketones, and proteinuria (microalbuminuria)
Autoantibodies: Anti-GAD, islet cell antibodies (to differentiate DM1 from DM2)
C-peptide levels: To assess endogenous insulin production (lower in DM1)
Lipid profile: For cardiovascular risk assessment
Kidney function tests: To check for diabetic nephropathy
Differential diagnosis
Type 1 vs. Type 2 Diabetes: Age of onset, body habitus, autoantibody presence
Maturity-Onset Diabetes of the Young (MODY): Genetic testing may be required
Gestational Diabetes: Diabetes diagnosed during pregnancy
Secondary Diabetes: Resulting from other conditions (e.g. Cushing’s syndrome, pancreatitis, medication-induced)
Other: Diabetic foot, gastroparesis, sexual dysfunction
9. Prognosis
Type 1 Diabetes: With good glycemic control, individuals can lead a normal, healthy life, though there is a lifelong dependence on insulin therapy. Poor control increases the risk of complications.
Type 2 Diabetes: Prognosis varies based on glycemic control, comorbidities, and adherence to treatment. Early diagnosis and lifestyle modifications significantly improve outcomes.
10. Prevention
Type 1 Diabetes
Currently, there is no effective method to prevent DM1. Research into immunomodulation and vaccine-like therapies is ongoing.
Type 2 Diabetes
Lifestyle Modifications: Regular physical activity, a balanced diet, and weight management are effective in preventing or delaying the onset of DM2, especially in high-risk individuals.
Medication: In some cases, metformin may be used in pre-diabetic patients to reduce the risk of progression to diabetes.
Top Tip
Work hard on patients with early DM2 (and prediabetes). You can help them slow its progression and even reverse it.